2-Aminopurine inhibits lipopolysaccharide-induced nitric oxide production by preventing IFN-β production

Microbiology and Immunology

Volumn 48, Issue 12, 2004, Pages 957-963

  Sugiyama, Tsuyoshi ^a,b   Fujita, Megumi ^a,b   Koide, Naoki ^a   Mori, Isamu ^a   Yoshida, Tomoaki ^a   Mori, Hiroshi ^b   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

2 Aminopurine; Lipopolysaccharides; Nitric oxide; Toll like receptors

Indexed keywords

2 AMINOPURINE; ADAPTOR PROTEIN; BETA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PROTEIN KINASE INHIBITOR; TOLL INTERLEUKIN 1 RECEPTOR DOMAIN CONTAINING ADAPTOR INDUCING INTERFERON BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; GENE; GENE EXPRESSION; GENE INDUCTION; IMMUNE RESPONSIVE GENE 1; MACROPHAGE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALIA; MURINAE;

EID: 11144267102     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03625.x     Document Type: Article

References (21)

1. Akira, S., Takeda, K., and Kaisho, T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
2. Alexopoulou, L., Holt, A.C., Medzhitov, R., and Flavell, R.A. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413: 732-738.
3. Du, W., Thanos, D., and Maniatis, T. 1993. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74: 887-898.
4. 15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138.
5. Horng, T., Barton, G.M., Flavell, R.A., and Medzhitov, R. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420: 329-333.
6. Horng, T., Barton, G.M., and Medzhitov, R. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2: 835-841.
7. Hoshino, K., Kaisho, T., Iwabe, T., Takeuchi, O., and Akira, S. 2002. Differential involvement of IFN-β in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14: 1225-1231.
8. Jarrous, N., Osman, F., and Kaempfer, R. 1996. 2-Aminopurine selectively inhibits splicing of tumor necrosis factor α mRNA. Mol. Cell. Biol. 16: 2814-2822.
9. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Muhlradt, P.F., Sato, S., Hoshino, K., and Akira, S. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167: 5887-5894.
10. Maggi, L.B., Jr., Moran, J.M., Buller, R.M., and Corbett, J.A. 2003. ERK activation is required for double-stranded RNA- and virus-induced interleukin-1 expression by macrophages. J. Biol. Chem. 278: 16683-16689.
11. McWhirter, S.M., Fitzgerald, K.A., Rosains, J., Rowe, D.C., Golenbock, D.T., and Maniatis, T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 101: 233-238.
12. Rao, K.M. 2000. Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health 3: 27-58.
13. Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., and Akira, S. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171: 4304-4310.
14. Takeda, K., and Akira, S. 2001. Roles of Toll-like receptors in innate immune responses. Genes Cells 6: 733-742.
15. Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19: 623-655.
16. Toshchakov, V., Jones, B.W., Perera, P.Y., Thomas, K., Cody, M.J., Zhang, S., Williams, B.R., Major, J., Hamilton, T.A., Fenton, M.J., and Vogel, S.N. 2002. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β- dependent gene expression in macrophages. Nat. Immunol. 3: 392-398.
17. Utaisincharoen, P., Anuntagool, N., Chaisuriya, P., Pichyangkul, S., and Sirisinha, S. 2002. CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). Clin. Exp. Immunol. 128: 467-473.
18. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., and Akira, S. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
19. Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T., Takeda, K., and Akira, S. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420: 324-329.
20. Yamamoto, M., Takeda, K., and Akira, S. 2004. TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol. 40: 861-868.
21. Yoneyama, M., Suhara, W., and Fujita, T. 2002. Control of IRF-3 activation by phosphorylation. J. Interferon Cytokine Res. 22: 73-76.